A broader look at paediatric HIV infection

Writing in PLoS Medicine, the CIPHER (Collaborative Initiative for Paediatric HIV Education and Research) Global Cohort Collaboration1 has shed light on the population of children who survive perinatal HIV infection, living into adolescence and beyond. [...]infant- and child-friendly formulations th...

Full description

Saved in:
Bibliographic Details
Published in:Nature (London) 2018-04, Vol.556 (7702), p.439-440
Main Author: Flynn, Patricia M
Format: Article
Language:English
Subjects:
Acquired immune deficiency syndrome
Age
AIDS
Antiretroviral agents
Child development
Children
Collaboration
Drug therapy
Epidemiology
High income
HIV
Human immunodeficiency virus
Infections
Infectious diseases
Low income groups
Pharmaceutical industry
Refrigeration
Researchers
Teenagers
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Writing in PLoS Medicine, the CIPHER (Collaborative Initiative for Paediatric HIV Education and Research) Global Cohort Collaboration1 has shed light on the population of children who survive perinatal HIV infection, living into adolescence and beyond. [...]infant- and child-friendly formulations that do not require refrigeration and are easy to transport are currently lacking. Because advances in preventing perinatal HIV infection have markedly decreased the numbers of infected children, there is unfortunately no longer a market benefit to developing paediatric ART, making it an unattractive focus for pharmaceutical companies. Patricia M. Flynn is in the Department of Infectious Diseases, St Jude Childrens Research Hospital, Memphis, Tennessee 38105, USA. e-mail: pat.flynn@stjude.org "Early antiretroviral therapy can save lives and preserve normal growth and development in children with HIV infection."
ISSN:0028-0836
1476-4687
DOI:10.1038/d41586-018-04476-8